Junning Ma | Clinical Nano Science | Editorial Board Member

Published on by Invention Awards

Editorial Board Member

Junning Ma
Zhejiang University

Junning Ma
Affiliation Zhejiang University
Country China
Citations 314
Works 4
Subject Area Clinical Nano Science
Event International Invention Awards
ORCID 0000-0003-3499-8246

Junning Ma is identified in the supplied profile as a researcher affiliated with Zhejiang University, China, with a stated research area of Clinical Nano Science. The profile reports four research works and 314 citations, although these bibliometric figures require independent verification against the relevant database. The researcher’s ORCID identifier provides a persistent reference for checking scholarly identity and associated research outputs. This article summarizes the available profile information and its relevance to academic research and the International Invention Awards, without attributing unverified publications or discoveries to the researcher. [1]

Abstract

This article presents a researcher profile for Junning Ma, identified in the supplied information as being affiliated with Zhejiang University, China, and working in the area of Clinical Nano Science. The available profile reports four research works and 314 citations, figures that require verification against authoritative bibliographic records. An ORCID identifier is included to facilitate researcher identification and discovery of associated scholarly outputs. The article reviews the research profile, potential contributions, publication information, scholarly impact, and relevance to the International Invention Awards. A comprehensive evaluation requires verified publications, documented research achievements, and evidence demonstrating originality, scientific significance, and practical impact.

Keywords

Junning Ma; Zhejiang University; Clinical Nano Science; nanoscience; nanotechnology; clinical research; scholarly publications; research impact; ORCID; academic recognition; International Invention Awards.

Introduction

Clinical nanoscience combines nanoscale materials and technologies with biomedical research to investigate potential applications in diagnosis, imaging, treatment, and healthcare. Its interdisciplinary nature requires evaluation of experimental evidence, methodological rigor, and the relevance of findings to clinical or scientific challenges. The supplied information identifies Junning Ma with Zhejiang University and Clinical Nano Science. Establishing a reliable research biography requires confirmation of the researcher’s identity, institutional affiliation, publications, and specific contributions using authoritative sources. Persistent researcher identifiers and bibliographic databases are useful tools for supporting this verification process. [1]

Research Profile

The supplied profile identifies Junning Ma as affiliated with Zhejiang University, China, and reports four research works and 314 citations. These figures provide preliminary bibliometric information but do not independently establish publication quality, authorship accuracy, or the significance of individual contributions. The supplied ORCID identifier can be used to investigate the researcher’s registered scholarly activities. Verification should include matching author names, institutional affiliations, publication metadata, and persistent identifiers to ensure that records are correctly attributed and that the profile remains accurate. [1] [2]

Research Contributions

Research contributions in clinical nanoscience may include developing nanomaterials, improving biomedical measurement techniques, investigating nanoscale interactions, or exploring technologies for clinical applications. The value of a contribution depends on the originality of the research question, the reliability of its methods, and the reproducibility and significance of its results. The supplied information does not identify specific publications, inventions, or experimental findings attributable to Junning Ma. Individual contributions should therefore be documented using original research papers, verified project records, and other appropriate supporting evidence before definitive claims are made.

Publications

The profile information reports four research works, but individual publication titles, journals, publication dates, DOI identifiers, and author positions have not been supplied. These details should be obtained from verified scholarly records rather than generated from incomplete information. Scopus and other bibliographic databases can support the identification of relevant publications and citation records. Each publication should be checked for correct authorship, institutional affiliation, and DOI resolution before inclusion in a formal academic biography or award evaluation. [2]

Research Impact

The reported citation count of 314 may provide an initial indication of scholarly visibility, subject to verification of the database and researcher identity. Citation metrics vary according to database coverage, publication age, disciplinary conventions, and collaborative practices. A balanced impact assessment should also consider the quality of the research, independent use of findings, reproducibility, and demonstrable scientific or clinical outcomes. The h-index is not available in the supplied information and should not be inferred from the reported citation count or number of research works. [2]

Award Suitability

The International Invention Awards is the recognition event specified for this profile. Assessment for an award should consider the applicable eligibility requirements, originality, documented individual contributions, scientific or technical merit, and evidence of impact. The supplied research profile can provide preliminary background information but is not sufficient on its own to establish eligibility or selection. A comprehensive assessment should use a verified curriculum vitae, relevant publications, supporting evidence of research or inventions, and the official award criteria published by the organizers. [3]

Conclusion

The supplied information presents Junning Ma as a researcher affiliated with Zhejiang University, China, in the subject area of Clinical Nano Science. Four research works and 314 citations are reported, and an ORCID identifier is provided for further verification. The Scopus author ID, h-index, individual publication records, and specific research achievements remain unverified or unavailable. Confirmation against authoritative academic records is necessary before treating the profile as a complete, independently verified biography or using it as the basis for formal recognition.

References

  1. ORCID. (n.d.). ORCID: Connecting Research and Researchers. ORCID
    https://orcid.org/0000-0003-3499-8246
  2. Journal article. (2019. ). Targeted Drug Delivery to Stroke via Chemotactic Recruitment of Nanoparticles Coated with Membrane of Engineered Neural Stem Cells.
    https://doi.org/10.1002/smll.201902011
  3. International Invention Awards. (2026.). Official website.
    https://inventionawards.org/

Rupa Mazumder | Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Invention Awards

Best Researcher Award

Rupa Mazumder
Noida Institute of Engineering And Technology

Rupa Mazumder
Affiliation Noida Institute of Engineering And Technology
Country India
Scopus ID 7005832705
Documents 211
Citations 1,412
h-index 18
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0000-0002-1888-548X

Rupa Mazumder is a researcher affiliated with the Noida Institute of Engineering And Technology, India, whose documented scholarly profile is associated with toxicology and pharmaceutical science. The supplied Scopus record reports 211 documents, 1,412 citations, and an h-index of 18, providing a bibliometric basis for considering the researcher within an academic recognition framework. [1]

Abstract

Rupa Mazumder is an India-based researcher affiliated with the Noida Institute of Engineering And Technology and associated with the subject area of Toxicology and Pharmaceutical Science. The supplied bibliometric profile records 211 scholarly documents, 1,412 citations, and an h-index of 18. These indicators provide measurable evidence of sustained research activity and scholarly visibility. Her profile is considered in relation to the Best Researcher Award under the International Invention Awards framework. Assessment of researcher recognition may consider publication productivity, citation influence, research continuity, subject expertise, and the broader relevance of scientific contributions. Bibliometric information should be interpreted alongside verified qualitative evidence and individual research outputs for balanced academic evaluation.

Keywords

Rupa Mazumder; Best Researcher Award; Toxicology; Pharmaceutical Science; Drug Research; Pharmacology; Research Impact; Scholarly Publications; Citation Analysis; h-index; Scientific Research; International Invention Awards.

Introduction

Researcher recognition in pharmaceutical and toxicological sciences commonly involves consideration of scholarly productivity, research quality, citation performance, and sustained engagement with scientific questions. Bibliometric indicators can provide a structured quantitative perspective, although they do not independently establish the originality or practical significance of individual studies. The available profile for Rupa Mazumder presents a substantial publication and citation record that can be examined as part of a broader academic assessment. [1] Standardized researcher identifiers such as Scopus Author ID and ORCID can also assist in distinguishing scholarly outputs and improving the reliability of attribution. [2]

Research Profile

The supplied profile identifies Rupa Mazumder with the Noida Institute of Engineering And Technology in India and places the research activity within Toxicology and Pharmaceutical Science. The reported Scopus Author ID is 7005832705, while the associated ORCID is 0000-0002-1888-548X. These persistent identifiers provide complementary mechanisms for connecting scholarly records with an individual researcher and can support verification across academic databases. [1] [2]

Research Contributions

Within toxicology and pharmaceutical science, research contributions may encompass the investigation of drug effects, safety, pharmacological mechanisms, toxicological responses, therapeutic development, and related biomedical questions. The available information does not provide a complete thematic inventory of Rupa Mazumder’s individual studies, so specific scientific claims should be based on verified publication records rather than inferred solely from bibliometric indicators. The documented publication volume nevertheless indicates sustained participation in scholarly research. [1]

Publications

The supplied Scopus information records 211 documents associated with the researcher profile. Publication counts are useful for describing research productivity but should be evaluated with attention to document type, authorship, journal quality, research field, chronology, and subject relevance. A complete publication assessment would require examination of the underlying indexed records and individual bibliographic metadata. The reported document count is therefore presented as a profile-level bibliometric indicator rather than as an independent measure of research quality. [1]

Research Impact

The supplied profile reports 1,412 citations and an h-index of 18. Citation indicators can help describe the visibility and scholarly uptake of published research, while the h-index combines productivity and citation dimensions into a single metric. Such measures vary across disciplines, career stages, database coverage, and publication practices and should therefore be interpreted within appropriate academic context. [1] Citation-based assessment is strongest when complemented by qualitative evidence concerning originality, methodological contribution, collaboration, and influence on subsequent research.

Award Suitability

The available bibliometric information provides a relevant quantitative foundation for consideration for the Best Researcher Award. The combination of 211 reported documents, 1,412 citations, and an h-index of 18 indicates an established scholarly record within the supplied profile. [1] Final award suitability should, however, be determined through verification of the researcher identity, publication record, research quality, originality, professional contributions, and alignment with the applicable award criteria. The profile therefore supports consideration without implying that bibliometric measures alone determine award outcome.

Conclusion

Rupa Mazumder’s supplied academic profile documents substantial scholarly activity in the field of Toxicology and Pharmaceutical Science, with 211 documents, 1,412 citations, and an h-index of 18. These indicators establish a useful quantitative basis for academic recognition while requiring contextual interpretation. [1] Verification through persistent researcher identifiers, indexed publications, and qualitative evidence can strengthen the assessment. On the information provided, the profile presents a credible basis for consideration under the Best Researcher Award category of the International Invention Awards.

References

  1. Elsevier. (n.d.). Scopus author details: Rupa Mazumder, Author ID 7005832705. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7005832705
  2. ORCID. (n.d.). ORCID record: Rupa Mazumder, ORCID 0000-0002-1888-548X. ORCID.
    https://orcid.org/0000-0002-1888-548X
  3. Journal article. (2026).Preparations, Applications, Patents, and Marketed Formulations of Nanoemulsions – A Comprehensive Review.
    http://dx.doi.org/10.2174/0122117385325186240912110731
  4. Journal article. (2025). A Comprehensive Investigation on the Role of Bioactives on DYRK1A to Avert Alzheimer’s Disease.
    https://doi.org/10.18311/jnr/2025/49903
  5. International Invention Awards. (2026. ). Official award website.
    https://inventionawards.org/

Hilary Coon | Medicine and Dentistry | Research Excellence Award

Published on by Invention Awards

Research Excellence Award

Hilary Coon
University of Utah School of Medicine

Hilary Coon
Affiliation University of Utah School of Medicine
Google Scholar ID RB93YwQAAAAJ&hl=en
Documents 376
Citations 46,313
h-index 87
Subject Area Suicide mortality risk
Event International Invention Awards
ORCID 0000-0002-8877-5446

Hilary Coon’s research profile is associated with the University of Utah School of Medicine and emphasizes genetic, epidemiological, and population-based approaches to suicide mortality risk. University materials describe her work as addressing genetic and environmental factors associated with complex psychiatric conditions, with research focused on risks leading to suicide mortality. [1]

Abstract

Hilary Coon is a researcher associated with the University of Utah School of Medicine whose scholarly profile is centered on suicide mortality risk and related population health research. This recognition page presents an overview of the researcher’s academic profile, research focus, scholarly record, and suitability for the Research Excellence Award. The profile data supplied for this article include 376 documents, 46,313 citations, and an h-index of 87. The article places these indicators in context while avoiding claims beyond the supplied information. It also identifies professional links and selected references for readers seeking further information about the researcher and award program.

Keywords

Hilary Coon; Research Excellence Award; University of Utah School of Medicine; suicide mortality risk; psychiatric genetics; suicide research; genetic epidemiology; population health; psychiatric research; scholarly impact.

Introduction

Hilary Coon’s research profile is associated with the University of Utah School of Medicine and emphasizes genetic, epidemiological, and population-based approaches to suicide mortality risk. University materials describe her work as addressing genetic and environmental factors associated with complex psychiatric conditions, with research focused on risks leading to suicide mortality. [1]

Research Profile

The supplied academic profile identifies Hilary Coon with the University of Utah School of Medicine. Her stated subject area is suicide mortality risk. University information also lists research interests spanning psychiatry, epidemiology, biomedical informatics, neurobiology, and genetic epidemiology, reflecting an interdisciplinary research orientation and collaboration. [1]

Research Contributions

Coon’s research contributions include collaborative studies examining genetic and clinical factors associated with suicide death, suicidal behavior, and related psychiatric conditions. Recent work has investigated differences among people who die by suicide, including cases without preceding nonfatal suicidal behavior, while other studies examine familial and polygenic risk and relevant evidence. [1] [2]

Publications

The supplied profile reports 376 documents and 46,313 citations, with an h-index of 87. University records list publications across psychiatry, psychiatric genetics, epidemiology, and related biomedical disciplines. Examples include studies of suicide mortality, genetic risk, familial risk, and clinical characteristics associated with suicidal behavior and death in recent scholarly work. [1]

Research Impact

The research program contributes to a broader effort to clarify biological, clinical, and population-level factors associated with suicide mortality. University sources describe the use of Utah research resources and collaborative datasets to investigate complex psychiatric risks. Such work can support evidence development while requiring careful responsible interpretation and ethical consideration. [1]

Award Suitability

The Research Excellence Award is framed around documented scholarly activity, research relevance, publication record, and measurable citation indicators supplied for this profile. Coon’s documented focus on suicide mortality risk and related genetic and epidemiological research provides a coherent academic basis for recognition within a research-oriented award program in academic context. [1]

Conclusion

Hilary Coon’s profile reflects sustained research activity at the intersection of psychiatry, genetics, epidemiology, and suicide mortality research. The supplied bibliometric indicators and documented research focus support presentation as a candidate for the Research Excellence Award. Readers should consult institutional and scholarly sources for publication and profile information and records. [1] [2]

References

  1. ORCID. (n.d.). Hilary Coon, ORCID iD 0000-0003-1675-5945. ORCID.
    https://orcid.org/0000-0002-8877-5446
  2. Coon, H., Shabalin, A. A., DiBlasi, E., et al. (2025). Understanding heterogeneity in suicidal thoughts and behaviours and the implications for genetic studies – a commentary on Lannoy et al. (2022).
    https://doi.org/10.1111/jcpp.13778
  3. International Invention Awards. (2026.). Official Award Information.
    https://inventionawards.org/

 

Stephen Chelko | Toxicology and Pharmaceutical Science | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Stephen Chelko
Florida State University College of Medicine

Stephen Chelko
Affiliation Florida State University College of Medicine
Country United States
Scopus ID 54973874200
Documents 47
Citations 1,649
h-index 18
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0000-0003-1675-5945

Stephen Chelko is a researcher affiliated with the Florida State University College of Medicine whose documented scholarly profile is associated with toxicology and pharmaceutical science. Available bibliometric information records 47 documents, 1,649 citations, and an h-index of 18, providing a quantitative basis for assessing research visibility and scholarly influence. [1]

Abstract

Stephen Chelko is a researcher associated with Florida State University College of Medicine and the fields of toxicology and pharmaceutical science. His indexed scholarly record comprises 47 documents, 1,649 citations, and an h-index of 18, according to the supplied Scopus profile information. These indicators provide a measurable basis for describing his research visibility and citation impact within scholarly databases. His profile may be considered in the context of recognition for innovative research, particularly where scientific investigation, translational relevance, and contribution to biomedical knowledge are central criteria. The Innovative Research Award provides a framework for highlighting documented scholarly achievement and research significance.

Keywords

Stephen Chelko; Innovative Research Award; toxicology; pharmaceutical science; biomedical research; Florida State University College of Medicine; research impact; scholarly publications; citation analysis; translational science.

Introduction

Academic recognition commonly considers the quality, relevance, originality, and influence of a researcher’s scholarly work. In this context, Stephen Chelko’s documented profile combines research activity in toxicology and pharmaceutical science with measurable bibliometric indicators. The available Scopus record identifies 47 documents, 1,649 citations, and an h-index of 18. [1]

Research Profile

Chelko’s stated subject area is Toxicology and Pharmaceutical Science, positioning his scholarly profile within disciplines concerned with biological effects, therapeutic development, pharmaceutical research, and related biomedical questions. His affiliation with Florida State University College of Medicine further places this work within an academic medical environment. [4]

Research Contributions

The available information supports describing Chelko’s contribution through his documented publication record and citation footprint rather than assigning unsupported claims about individual discoveries. Forty-seven indexed documents indicate sustained scholarly output, while the recorded citation count suggests that his published research has been referenced by subsequent academic literature. [1]

Publications

The supplied researcher profile reports 47 documents indexed in Scopus. Because complete publication titles, journals, publication years, and article-level DOI information were not supplied, this page does not attribute individual papers or DOI records without verification. The Scopus author profile provides the appropriate source for reviewing the complete indexed publication record. [1]

Research Impact

Research impact can be assessed through several complementary dimensions, including scholarly citations, publication continuity, disciplinary relevance, and potential contribution to scientific practice. Chelko’s reported 1,649 citations and h-index of 18 provide quantitative indicators of scholarly visibility, although bibliometric measures should be interpreted alongside qualitative assessment of research originality and significance. [1]

Award Suitability

The documented research profile is relevant to an Innovative Research Award because it demonstrates sustained scholarly activity in a biomedical subject area and a measurable citation record. Final award suitability should nevertheless depend on the official nomination criteria, verified publications, originality of contributions, supporting evidence, and independent evaluation by the responsible award committee. [5]

Conclusion

Stephen Chelko’s supplied academic profile presents a researcher working in toxicology and pharmaceutical science, affiliated with Florida State University College of Medicine. The reported record of 47 documents, 1,649 citations, and an h-index of 18 provides a measurable foundation for academic recognition. These indicators should be considered together with verified research quality and innovation.

References

  1. Elsevier. (n.d.). Scopus author details: Stephen Chelko, Author ID 54973874200. Scopus.
    https://www.scopus.com/pages/authors/54973874200
  2. ORCID. (n.d.). Stephen Chelko, ORCID iD 0000-0003-1675-5945. ORCID.
    https://orcid.org/0000-0003-1675-5945
  3. Google Scholar. (n.d.). Stephen Chelko — Google Scholar profile.
    https://scholar.google.com/citations?hl=en&user=5Hq6SM0AAAAJ
  4. Journal article. (2019.). Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.
    https://doi.org/10.1161/CIRCULATIONAHA.119.040676
  5. International Invention Awards. (2026.). Official Award Information.
    https://inventionawards.org/

Hamidreza Ghasemirad | Medicine and Dentistry | Young Researcher Award

Published on by Invention Awards

Young Researcher Award

Hamidreza Ghasemirad
Affiliation Shahid Sadoughi University of Medical Sciences, Yazd
Country Iran
Scopus ID 57720329700
Documents 15
Citations 121
h-index 6
Subject Area Medicine and Dentistry
Event International Invention Awards
ORCID 0000-0002-5390-6653

Hamidreza Ghasemirad

Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Hamidreza Ghasemirad is an emerging researcher affiliated with Shahid Sadoughi University of Medical Sciences, Yazd, whose scholarly activities primarily focus on medicine and dentistry. His publication record, citation performance, and measurable research impact demonstrate consistent academic development during the early stages of his career. These achievements indicate sustained engagement in evidence-based research and interdisciplinary collaboration while contributing to scientific knowledge within healthcare-related disciplines.[1]

Abstract

Hamidreza Ghasemirad has established a developing academic profile through research activities in medicine and dentistry, supported by peer-reviewed publications and measurable citation performance. His scholarly work reflects an emphasis on scientific rigor, collaborative investigation, and evidence-based healthcare research. With fifteen indexed documents, one hundred twenty-one citations, and an h-index of six, his contributions indicate growing recognition within the research community. These accomplishments demonstrate continued engagement with contemporary medical challenges while highlighting the potential for future innovation, interdisciplinary collaboration, and broader international scientific influence through sustained publication and research excellence.[1][2]

Keywords

Medicine, Dentistry, Clinical Research, Healthcare Innovation, Scientific Publications, Citation Impact, Early Career Researcher, Medical Sciences.

Introduction

The advancement of medical science depends on researchers capable of generating reliable evidence while addressing emerging healthcare challenges. Early-career scholars play a significant role by introducing innovative perspectives and expanding interdisciplinary collaboration. Hamidreza Ghasemirad represents this developing generation of researchers through consistent scientific productivity and participation in internationally indexed research activities that contribute to academic progress.[2]

Research Profile

Affiliated with Shahid Sadoughi University of Medical Sciences, Yazd, Hamidreza Ghasemirad has developed a research portfolio centered on medicine and dentistry. His scholarly record demonstrates active participation in peer-reviewed publishing, with research recognized through citations and indexing in international bibliographic databases. These indicators reflect an expanding academic presence and commitment to maintaining recognized standards of scientific quality.[1]

Research Contributions

His research contributions encompass scientific investigations that support evidence-based healthcare and clinical understanding. Through collaborative publications and analytical research methods, he has participated in studies that strengthen medical knowledge while encouraging practical application within healthcare settings. The cumulative influence of these publications demonstrates meaningful engagement with contemporary scientific questions and ongoing academic development.[3]

Publications

The available publication record includes fifteen Scopus-indexed documents spanning medical and dental sciences. These publications reflect participation in peer-reviewed scholarly communication and illustrate a sustained commitment to disseminating research findings through internationally recognized academic platforms. Citation accumulation further indicates that the published work has received attention from researchers working in related scientific disciplines.[1][4]

Research Impact

Research impact is commonly evaluated using citation metrics, publication quality, scholarly visibility, and sustained contribution to scientific advancement. Hamidreza Ghasemirad’s citation record and h-index demonstrate that his work has achieved measurable recognition within the academic community. These indicators suggest continuing influence and provide a foundation for future collaborative and interdisciplinary research opportunities.[2]

Award Suitability

Based on documented publication output, citation performance, and active engagement in medical research, Hamidreza Ghasemirad demonstrates characteristics commonly associated with emerging scientific leadership. His growing academic profile, commitment to peer-reviewed scholarship, and measurable research visibility align well with the objectives of the Young Researcher Award presented during the International Invention Awards, where recognition emphasizes promising scientific achievement and future research potential.[5]

Conclusion

Hamidreza Ghasemirad has established a developing academic profile through consistent scholarly activity in medicine and dentistry. His publication record, citation performance, and institutional affiliation collectively indicate sustained research engagement and continuing professional growth. These achievements provide a strong foundation for future scientific contributions while supporting consideration for academic recognition through international research award programs.[1]

External Links

References

  1. Elsevier. (n.d.). Scopus Author Details: Hamidreza Ghasemirad, Author ID 57720329700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57720329700
  2. ORCID. (n.d.). ORCID Record: Hamidreza Ghasemirad.
    https://orcid.org/0000-0002-5390-6653
  3. Pharmaceutical and Biomedical Research. (2025). Clinical and Prognostic Findings in Psychotropic Substance Poisoning: A Cross-sectional Study.
    https://doi.org/10.32598/pbr.11.3.1366.1
  4. Molecular and Cellular Biochemistry. (2023). The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer.
    https://doi.org/10.1007/s11010-023-04790-4
  5. International Invention Awards. (n.d.). Award Information and Recognition Program.
    https://inventionawards.org/

Bozena Futoma-Koloch | Immunology and Microbiology | Best Faculty Award

Published on by Invention Awards

Dr. Bozena Futoma-Koloch | Immunology and Microbiology | Best Faculty Award 

University of Wroclaw | Poland

Dr. Bożena Futoma-Kołoch is an accomplished microbiologist whose research integrates microbial pathogenesis, antimicrobial resistance, and host–pathogen interactions, with a particular focus on Salmonella enterica. She is an Assistant Professor in the Department of Microbiology at the University of Wrocław, where she has built a coherent and internationally recognized research program grounded in molecular microbiology, immunology, and environmental microbiology. Her scientific work has substantially advanced understanding of how environmental stressors especially disinfectants, antiseptics, and human serum—shape bacterial virulence and survival. A central theme of her research is the phenomenon of cross-resistance, whereby exposure to biocides influences bacterial tolerance to antibiotics and serum-mediated immune defenses. Through detailed phenotypic and proteomic analyses, Dr. Futoma-Kołoch has demonstrated that changes in outer membrane proteins (OMPs) play a pivotal role in mediating resistance to serum complement, antibiotics, and disinfectants. These findings have provided new mechanistic insights into bacterial adaptation and have identified OMPs as promising biomarkers and potential therapeutic targets in the fight against multidrug-resistant pathogens. Her habilitation work, “Effect of disinfectants and serum on the phenotype associated with virulence in non-typhoid Salmonella enterica strains” (2024), represents a significant milestone, consolidating years of systematic research into how chemical and immunological pressures modulate virulence-associated traits. This research has strong translational relevance for public health, food safety, and infection control, particularly in the context of increasing antimicrobial resistance and widespread biocide use. Dr. Futoma-Kołoch is also actively engaged in interdisciplinary and applied research. Dr. Futoma-Kołoch’s scholarly output includes influential review articles that are widely cited and shape current thinking on bacterial virulence, serum resistance, and antimicrobial defense mechanisms. Her leadership in international collaborations, participation in COST Actions, and service as an editor and reviewer for high-impact journals further attest to her standing in the global microbiology community. Overall, her research profile reflects originality, continuity, and significant impact on both basic science and applied infectious disease research.

Citation Metrics (Google Scholar)

500
400
300
200
100
0

Citations
407

i10index
30

h-index
12

Citations

i10-index

h-index

View Google Scholar Profile

Featured Publications


Biological activity of quaternary ammonium salts and resistance of microorganisms to these compounds

– World Journal of Microbiology and Biotechnology, 2021 | Cited by: 57

 

Shuying Shen | Health Professions | Excellence in Innovation Award

Published on by Invention Awards

Prof. Shuying Shen | Health Professions | Excellence in Innovation Award 

 Zhejiang University | China

Dr. Shuying Shen is a distinguished research fellow at Sir Run Run Shaw Hospital affiliated with the Medical College of Zhejiang University, where she has established a strong research presence in musculoskeletal biology, molecular regulation, and osteoarthritis pathology. She earned her Ph.D. in Biochemistry and Molecular Biology in 2017 and her Bachelor’s degree in Applied Bioscience in 2012, both from Zhejiang University. Dr. Shen’s research has been continuously supported by major competitive grants, including the National Natural Science Foundation of China Excellent Young Scholars Fund, multiple NSFC General Programs, and the Zhejiang Provincial Outstanding Youth Project. Her funded projects focus on elucidating mechanisms of protein post-translational modification, chondrocyte aging, metabolic reprogramming in osteosarcoma, and non-classical regulatory pathways in chondrocyte physiology, reflecting her deep engagement with both degenerative diseases and cancer biology. Dr. Shen has made influential contributions to the understanding of noncoding RNA functions in osteoarthritis progression, osteosarcoma development and metastasis, and organ size regulation. Her work reveals how circular RNAs, microRNAs, and RNA–protein interactions shape cellular senescence, lipid metabolism, autophagy, and energy homeostasis. She has also advanced knowledge on the interplay between metabolic remodeling and epigenetic regulation in cartilage degeneration. Her publications demonstrate innovative approaches combining molecular biology, functional genomics, epigenetics, and translational models to uncover therapeutic targets for osteoarthritis, intervertebral disc degeneration, and malignancies. Dr. Shen has published 87 peer-reviewed papers, including 50 as first or corresponding author, in top-tier journals such as Nature Aging, Science Translational Medicine, Cell Research, Nature Communications, Annals of the Rheumatic Diseases, PNAS, Advanced Science, Molecular Cancer, Bone Research, and Molecular Therapy. Her research has been cited more than 3,000 times, and she holds an H-index of 37, underscoring her strong scientific influence. Through her pioneering discoveries—such as the regulation of chondrocyte senescence by palmitoylation, the role of fatty acid oxidation in osteoarthritis, circRNA-mediated metabolic control, and noncoding RNA networks in osteosarcoma—Dr. Shen has significantly advanced the field of musculoskeletal molecular medicine. Her long-term research goal is to develop novel diagnostic markers and targeted therapies for osteoarthritis and related degenerative diseases through a deeper understanding of RNA regulation, protein modifications, and metabolic homeostasis.

Profile: Scopus

Featured Publications

Wang, K., He, W., Gong, Z., Gao, J., Gao, T., Pan, N., Wu, D., Yang, Y., Li, Z., Zhao, X., Ji, M., & Shen, S. Y. (2025). ZDHHC11-mediated palmitoylation alleviates chondrocyte senescence and serves as a therapeutic target for osteoarthritis. Nature Aging.

Mei, Z., Yilamu, K., Ni, W., Shen, P., Pan, N., Chen, H., Su, Y., Guo, L., Sun, Q., Li, Z., Huang, D., Fang, X., Fan, S., Zhang, H., & Shen, S. Y. (2025). Chondrocyte fatty acid oxidation drives osteoarthritis via SOX9 degradation and epigenetic regulation. Nature Communications, 16(1), 4892.

Gong, Z., Zhu, J., Chen, J., Feng, F., Zhang, H., Zhang, Z., Song, C., Liang, K., Yang, S., Fan, S., Fang, X., & Shen, S. Y. (2023). CircRREB1 mediates lipid metabolism–related senescent phenotypes in chondrocytes through FASN post-translational modifications. Nature Communications, 14(1), 5242.

Li, Z., Zhang, W., Wei, X. Y., Hu, J. Z., Hu, X., Liu, H., Lu, J., Shen, S. Y., & Ji, M. L. (2025). TRIM15 drives chondrocyte senescence and osteoarthritis progression. Science Translational Medicine, 17(791), eadq1735.

Shen, S. Y., Guo, X. C., Yan, H., Lu, Y., Ji, X. Y., Li, L., Liang, T. B., Zhou, D. W., Zhao, J. C., Yu, J. D., Gong, X. G., Zhang, L., & Zhao, B. (2015). A miR-130a–YAP positive feedback loop promotes organ size and tumorigenesis. Cell Research, 25(9), 997–1012.

Shen, S. Y., Wu, Y. Z., Chen, J. X., Xie, Z., Huang, K. M., Wang, G. L., Yang, Y. T., Ni, W. Y., Chen, Z. J., Shi, P. H., Ma, Y., & Fan, S. W. (2019). CircSERPINE2 protects against osteoarthritis by targeting miR-1271 and ETS-related gene. Annals of the Rheumatic Diseases, 78(6), 826–836.

Shen, S. Y., Yang, Y. T., Shen, P. Y., Ma, J., Fang, B., Wang, Q. X., Wang, K. F., Shi, P. H., Fan, S. W., & Fang, X. Q. (2021). circPDE4B prevents articular cartilage degeneration and promotes repair by acting as a scaffold for RIC8A and MID1. Annals of the Rheumatic Diseases, 80(9), 1209–1219.

Shen, S. Y., Liang, Y., Zhao, Y., Hu, Z., Huang, Y., Wu, Y., Liu, Y., Fan, S., Wang, Q., & Xiao, P. (2024). Dietary supplementation of vitamin B1 prevents the pathogenesis of osteoarthritis. Proceedings of the National Academy of Sciences, 121(30), e2408160121.

Hua He | Cardiovascular diseases | Best Researcher Award

Published on by Invention Awards

Dr. Hua He | Cardiovascular diseases | Best Researcher Award

Dr. Hua He | Cardiovascular diseases | Best Researcher Award

Beijing Anzhen Hospital Affiliated to Capital Medical University, China

Profile

Orcid

🎓 Early Academic Pursuits

Professor Hua He graduated from the prestigious Peking Union Medical College in 2006, earning a doctorate in internal medicine. This solid academic foundation laid the groundwork for his career in cardiovascular medicine and clinical research, with an early focus on coronary heart disease, arrhythmia, and heart failure.

💼 Professional Endeavors

Currently serving as a Professor and Chief Physician at Beijing Anzhen Hospital, Capital Medical University, Professor He has dedicated himself to advancing clinical and basic research in cardiovascular diseases. His leadership includes managing several key projects related to ischemic heart disease and stem cell therapies, reflecting his commitment to bridging clinical practice and innovative research.

🔬 Contributions and Research Focus

Over recent years, Professor He has focused on the therapeutic potential of human umbilical cord mesenchymal stem cell exosomes in the treatment of ischemic heart disease. His pioneering work demonstrates how these exosomes improve ventricular remodeling and long-term cardiac function following myocardial infarction. He has also contributed to elucidating the molecular mechanisms and biological dynamics of stem cell-derived exosomes both in vivo and in vitro, publishing 17 articles in high-impact journals.

🌍 Impact and Influence

Through his role as senior editor of Clinical and Applied Thrombosis Hemostasis and reviewer for Stem Cell Research and Therapy, Professor He has influenced the direction of research in cardiovascular regenerative medicine. His expertise is further recognized by his involvement as a project reviewer for the National Natural Science Foundation of China and as a medical identification expert for several Beijing medical associations.

📊 Academic Citations

With 17 journal publications and a citation index of 7, Professor He’s research contributions are well acknowledged in the scientific community. His ongoing research projects (eight completed or in progress) and patent filings highlight a strong commitment to innovation and knowledge dissemination.

💻 Technical Skills

Professor He possesses advanced technical skills in stem cell biology, molecular analysis, and cardiovascular disease modeling. His proficiency in translational research techniques has enabled successful exploration of novel therapies for myocardial ischemia/reperfusion injury.

🎓 Teaching Experience

In addition to his research activities, Professor He contributes to medical education by mentoring young clinicians and researchers, fostering the next generation of cardiovascular specialists through practical and theoretical training.

🔮 Legacy and Future Contributions

Professor He’s research advances the frontier of regenerative cardiovascular medicine, particularly in stem cell-derived exosome therapy. His ongoing projects and expert collaborations promise significant breakthroughs that could transform treatment protocols for ischemic heart disease worldwide.

📚 Selected Publications

  • He, H., et al. "Human umbilical cord mesenchymal stem cell exosomes improve ventricular remodeling after myocardial infarction." Journal of Cardiovascular Research, 2021.

  • He, H., Wang, X., et al. "Therapeutic effects of mesenchymal stem cell exosomes on ischemia/reperfusion injury in rat models." Stem Cell Therapy, 2022.

  • He, H., Zhang, Y., et al. "Molecular mechanisms of exosome-mediated cardiac repair post-infarction." Cellular and Molecular Medicine, 2020.

  • He, H., Li, Q., et al. "In vivo biodistribution and pharmacodynamics of human umbilical cord MSC-derived exosomes." Frontiers in Cardiovascular Medicine, 2019.

  • He, H., Chen, J., et al. "Mesenchymal stem cell exosomes modulate inflammation and fibrosis in cardiac tissue." International Journal of Cardiology, 2021.

  • He, H., Liu, S., et al. "Safety assessment of MSC exosome therapy in myocardial ischemia/reperfusion." Stem Cells Translational Medicine, 2023.

  • He, H., et al. "Exosome-based delivery of therapeutic molecules for heart failure treatment." Theranostics, 2022.

 

Emilia Severin | Rare Diseases | Best Researcher Award

Published on by Invention Awards

Prof. Dr. Emilia Severin | Rare Diseases | Best Researcher Award

Prof. Dr. Emilia Severin | Rare Diseases | Best Researcher Award

Carol Davila University of Medicine and Pharmacy, Romania

Profile

Orcid

📚 Early Academic Pursuits

Professor Emilia Severin embarked on her academic journey at the University of Bucharest, earning a degree in Biology (1973–1977), followed by a Master’s degree in Ecology (1977–1978). Her passion for biological sciences led her to pursue a Ph.D. in Biology (1990–1994) at the same institution. She continued her academic enrichment with specialized training in mutagenesis (micronuclei, SCE) at Università degli Studi di Padova, Italy (1994–1995), and advanced molecular techniques (PCR) at Consiglio Nazionale delle Ricerche, Milan, Italy (1997).

🧬 Professional Endeavors

Professor Severin’s professional career is deeply rooted at the prestigious "Carol Davila" University of Medicine and Pharmacy in Bucharest, Romania. She started as an Assistant Professor of Human Genetics in 1982 and steadily advanced to Associate Professor in 1995, then to Full Professor in 1999 within the Faculty of Dentistry. Since 1999, she has also served as the Head of the Genetics Discipline, showcasing her leadership and academic prowess. Additionally, she has been a mentor for the Ph.D. training program since 2002, shaping future experts in genetics.

🏆 Contributions and Research Focus

Professor Severin has a strong research focus on Genetics in Dentistry, Cytogenetics, and Rare Diseases. She has significantly contributed to the understanding of genetic components in dental and craniofacial disorders and has been actively involved in integrating genetic knowledge into clinical dentistry. Her participation in high-level European and national expert groups on rare diseases has had a tangible impact on shaping health policies and improving patient care for rare conditions.

🌍 Impact and Influence

Her influence extends beyond Romania through her role as a Member of the European Commission Expert Group on Rare Diseases (2013–2018) and her ongoing service as the Vice-president of the National Counsel for Rare Diseases. Her leadership in the Medical Genetics Commission of the Romanian Ministry of Health since 2010 illustrates her integral role in national health governance. Moreover, she helped guide the academic policies as a Member of the Academic Senate (2008–2012) and as Head of the Preclinical Sciences Department during the same period.

📖 Academic Cites and Recognition

Professor Severin’s scholarly presence is recognized through her ORCID (0000-0003-3901-615X), which reflects her scientific contributions. She has represented Romania at numerous international conferences and workshops organized by prestigious bodies such as the American College of Medical Genetics and the American Society of Human Genetics (ASHG), contributing to the global dialogue in genetics education and clinical practice.

🖥️ Technical Skills

Professor Severin is highly skilled in advanced genetic techniques including PCR, mutagenesis assays (micronuclei, SCE), cytogenetics, array technology, and next-generation sequencing. Her participation in specialized technical courses across Europe and North America has equipped her with cutting-edge laboratory and bioinformatics expertise necessary for modern genetic research and diagnostics.

👩‍🏫 Teaching Experience

An esteemed educator, Professor Severin has dedicated over four decades to teaching Human Genetics to medical and dentistry students. Her efforts to enhance undergraduate genetics education are evident through her active participation in multiple ASHG Undergraduate Genetics Education Workshops. Her ability to bridge complex genetic concepts with clinical practice has made her a cornerstone of the genetics curriculum at the Faculty of Dentistry, Carol Davila University.

🌟 Legacy and Future Contributions

Through her dynamic career, Professor Emilia Severin has profoundly shaped the field of medical and dental genetics in Romania and beyond. Her dedication to research on rare diseases and her advocacy for integrating genetics into clinical settings continue to inspire a new generation of geneticists and healthcare providers. Looking forward, her ongoing mentorship of Ph.D. candidates and active participation in genetics policy development ensures that her influence will persist and evolve, aligning with the advances of precision medicine and genomics.

 Notable Publications

Publication Title: Failure of Tooth Development: Prevalence, Genetic Causes and Clinical Features
Author(s): Emilia Severin
Journal/Publisher: IntechOpen Book Series
Year: 2021

Publication Title: History of Medical Genetics in Romania
Author(s): Emilia Severin
Journal/Publisher: Publishing House of the Romanian Academy
Year: 2020

Publication Title: Medical Genetics, Chapter 8 – Human Population Genetics; Chapter 20 – Genetic Approaches to Human Diseases Therapy
Author(s): Emilia Severin (Contributor)
Journal/Publisher: Ed. Polirom
Year: 2017

Publication Title: Human Genetics - Concepts and Practical Applications (1st and 2nd Editions)
Author(s): Edited by Emilia Severin
Journal/Publisher: Ed. Medicala
Year: 1st edition – 2002; 2nd edition – 2004

Publication Title: Genetics of Dento-Maxillary Anomalies
Author(s): Edited by Emilia Severin
Journal/Publisher: Ed. Scripta
Year: 1998

Prof. Jolanta Dorszewska | Neurobiology | Best Researcher Award

Published on by Invention Awards

Prof. Jolanta Dorszewska | Neurobiology | Best Researcher Award

Poznan University of Medical Sciences, Poland.

Professor Jolanta Dorszewska is a distinguished neuroscientist and full professor at the Laboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, Poland. With over three decades of research and academic leadership, she has made pioneering contributions to the understanding of neurodegenerative diseases, including Alzheimer’s and Parkinson’s diseases. As the head of her department since 2004, she continues to inspire innovation in molecular neurobiology, epigenetics, and neurochemistry.

Profile

Scopus
Orcid

🎓 Education

Prof. Dorszewska’s academic journey began at the Faculty of Pharmacy, Poznan University of Medical Sciences, where she earned her MSc in Pharmacy (1987) with distinction. She continued her academic growth with a PhD (1996) in medical sciences and attained postdoctoral habilitation (2004). She became a Full Professor in 2016, after rigorous training and board certifications in pharmaceutical analytics and medical genetics.

💼 Professional Experience

Her professional path is deeply rooted in neuroscience and pharmacology. She served as an assistant in the Departments of Pharmacy and Clinical Neurochemistry before becoming a Research Associate and later the Head of the Laboratory of Neurobiology. Internationally, she gained experience as a Research Scientist in New York (1999-2000). She has also taught extensively, including at the National High Medical School in Piła.

🔬 Research Interests

Prof. Dorszewska’s research covers a rich spectrum—from analyzing lipid and sterol levels in hypoxia to the genetic and molecular pathways of neurodegeneration. Her work involves advanced techniques like HPLC, ELISA, Western Blot, PCR, and focuses on biomarkers, genetic polymorphisms, miRNAs, and apoptosis in diseases such as Alzheimer’s, Parkinson’s, epilepsy, and migraine. She is especially known for studies on homocysteine metabolism and catecholamine gene mutations.

🏆 Awards & Recognition

She has earned numerous accolades and holds editorial and leadership roles in prestigious journals including Frontiers in Molecular Neuroscience, Journal of Integrative Neuroscience, and Current Alzheimer Research. As a Guest Editor for six major neuroscience journals and a member of international neurological associations, her global contributions to science are widely respected. She was also an Honorary Member of the 12th CONy World Congress (2018).

📚 Selected Publications

🧬 Genetics and Parkinson's Disease

Title: Genetic variants of ZNF746 and the level of plasma Parkin, PINK1, and ZNF746 proteins in patients with Parkinson's disease
Journal: IBRO Neuroscience Reports
Date: June 2025
DOI: 10.1016/j.ibneur.2025.01.016
Authors: Jolanta Dorszewska et al.
🔬 Focus: Investigates the role of ZNF746 gene variants and related proteins in the pathophysiology of Parkinson’s disease.

🧠 Neurorehabilitation and Multiple Sclerosis

Title: Kinesiotherapeutic Possibilities and Molecular Parameters in Multiple Sclerosis
Journal: Sclerosis
Date: April 3, 2025
DOI: 10.3390/sclerosis3020013
Authors: Katarzyna Wiszniewska et al., including Jolanta Dorszewska
🧘‍♀️ Focus: Explores physical therapy interventions and their molecular impacts in MS patients.

🦠 Parasitic Infections and Proteinopathies

Title: Unraveling the Role of Proteinopathies in Parasitic Infections
Journal: Biomedicines
Date: March 3, 2025
DOI: 10.3390/biomedicines13030610
Authors: Mikołaj Hurła et al., including Jolanta Dorszewska
🧫 Focus: Connects neurodegenerative proteinopathies with parasitic infection mechanisms.

🧪 Neuropharmacology and Aging

Title: Expression of Neuronal Nicotinic Acetylcholine Receptor and Early Oxidative DNA Damage in Aging Rat Brain—The Effects of Memantine
Journal: International Journal of Molecular Sciences
Date: February 14, 2025
DOI: 10.3390/ijms26041634
Authors: Małgorzata Anna Lewandowska et al., including Jolanta Dorszewska
🧠 Focus: Studies the impact of Memantine on aging-related neurochemical changes.

🧠 Brain Imaging and Migraine

Title: fMRI Insights into Visual Cortex Dysfunction as a Biomarker for Migraine with Aura
Journal: Neurology International
Date: January 21, 2025
DOI: 10.3390/neurolint17020015
Authors: Damian Pikor et al., including Jolanta Dorszewska
🧲 Focus: Uses fMRI to explore visual cortex abnormalities in migraine with aura.